Older Americans Quit Weight-Loss Drugs in Droves In some studies, half of patients stopped taking GLP-1s within a year despite the benefits, citing the expense and side effects. Previous article: Estados limitan la cobertura de una terapia de referencia para el autismo. Y las familias reaccionan Prev Next article: On the Hook for Uninsured Residents, Counties Now Wonder How They’ll Pay Next
